MC1R and melanoma: Heterodimer [18F]4 thus demonstrated an excellent receptor-specific tumor visualization ability and impressively illustrated the suitability of the underlying concept to develop heterobivalent integrin αvβ3- and MC1R-bispecific radioligands for the sensitive and specific imaging of malignant melanoma by PET/CT.